Basket Updated
0
Items added
Researchers combined their expertise to successfully pioneer a new path towards identifying the ubiquitous protein modification O-GlcNAcylation.
It was too difficult for scientists to uncover the peptides for which they enriched, so scientists from the Broad Institute and CST® created a new method.
SignalScan bridges the gap between PCR-based detection of COVID-19 infection and uncovering the molecular signature of infection and host immune response.
Control peptides can be used to ensure reproducibility in proteomics experiments conducted with PTMScan.
To study pathways regulated by nitrotyrosine, CST offers two recombinant monoclonal antibodies against the same PTM for WB and proteomic applications.
What if an antibody could identify a PTM, regardless of the flanking amino acid sequence? This innovative idea is the basis of CST's PTMScan product line.